Destiny Pharma

United Kingdom
Coalisland, Northern Ireland, United Kingdom, BN1 9SB

Company profile

Destiny Pharma company profile

Destiny Pharma is an innovative pharmaceutical company dedicated to the development of novel antimicrobial products. Our XF series of compounds have a mechanism of action that is fundamentally different from all existing antibiotics. As the likelihood of resistance developing is very remote, they offer potential advantages in controlling the drug-resistant bacteria that are at the centre of a global healthcare crisis.

Business identity

Contact email
[email protected]
Phone number
+441273704499
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
1996-01-01, Year

Headquarters

Postal code
BN1 9SB
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
7
Total equity funding
$53.3M
Last funding
Post IPO Equity / $8.9M / 2023-03-16
Last equity funding
Post IPO Equity / $8.9M
Investors
9
Lead investors
6
Founders
1
Articles
64
Exited on
2017-09-08

Founders and investors

Founders

William Love

Lead investors

ACF InvestorsAntimicrobial resistanceChina Medical System Holdings LimitedCMS Medical Venture InvestmentCystic Fibrosis FoundationLongbow Capital

Investors

ACF InvestorsCystic Fibrosis FoundationDowning LLPDowning VenturesJuno Capital Partners